• Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
  • Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
  • Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
  • Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
  • Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
  • Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide

Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide

CAS No.: 2023788-19-2
Formula: C225h348n48o68
EINECS: /
Type: Agrochemical Intermediates
Appearance: Powder
Quality: Industrial
Samples:
US$ 50/mg 1 mg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
Overview

Basic Info.

Model NO.
D-sung Tirzepatide
Colour
White
Product Name
Tirzepatide
Name
Tirzepatide Powder
Molecular Formu
C225h348n48o68
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Agriculture
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
Molecular Weight
4813.45
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Xi′an Shaanxi
Production Capacity
10kg/Month

Product Description

Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
Product Description

 

Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
Product Details

 

Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide
Product name Tirzepatide
Purity 99%
Appearance White powder
CAS NO 2023788-19-2
Molecular Formula C225H348N48O68
Shelf life 2 years
Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.
Application&Function

 

Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatideTesipatide is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Pharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes TirzepatidePharmaceutical Intermediates Tirzepatide CAS 2023788-19-2 Tirzepatide Peptide Anti-Diabetes Tirzepatide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP